Article Summary:
RiseMalaysia – Sept 2022
Lung Cancer Network Malaysia (LCNM) and AstraZeneca launched another strategic collaboration to broaden access to lung cancer diagnosis utilising advanced technologies. They are introducing the Free Lung Cancer Screening Campaign.
Lung Cancer Network Malaysia (LCNM) and AstraZeneca, together with Qualitas Medical Group once again partnered with three leading tertiary private cancer facilities; Beacon Hospital, Subang Jaya Medical Centre and Sunway Medical Centre to provide free lung cancer screening to Malaysians.
This is to help the public get an easier access to cutting-edge Artificial Intelligence (AI) screening technology (Qure.ai) at primary care clinics and if extra attention needed, will be further investigated with a low-dose computed tomography (LDCT) scan at the three partner tertiary care hospitals.
This collaboration wished to spark a new hope for Malaysians to take their healthcare seriously. As in any healthcare issue, the prominent process of it is the detection. If it could be done early, further cure and treatment can be done as soon as possible.
The free screening campaign is going to be available until 31 December 2022, at 12 Qualitas primary care clinics.
For more information on the free screening campaign, please visit: https://www.beaconhospital.com.my/monthly-offers/free-low-dose-ct-scan/
